These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

131 related items for PubMed ID: 6223907

  • 1. Teichomycin: in-vitro and in-vivo evaluation in comparison with other antibiotics.
    Pallanza R, Berti M, Goldstein BP, Mapelli E, Randisi E, Scotti R, Arioli V.
    J Antimicrob Chemother; 1983 May; 11(5):419-25. PubMed ID: 6223907
    [Abstract] [Full Text] [Related]

  • 2. In vitro activity of teichomycin against isolates of gram-positive bacteria.
    Fietta A, Bersani C, Mangiarotti P, Gialdroni Grassi G.
    Chemotherapy; 1983 May; 29(4):275-82. PubMed ID: 6223793
    [Abstract] [Full Text] [Related]

  • 3. In vitro activity of teichomycin compared with those of other antibiotics.
    Neu HC, Labthavikul P.
    Antimicrob Agents Chemother; 1983 Sep; 24(3):425-8. PubMed ID: 6227282
    [Abstract] [Full Text] [Related]

  • 4. Bactericidal activity of teicoplanin in an in-vitro two-compartment kinetic model.
    Pallanza R, Scotti R, Arioli V.
    J Antimicrob Chemother; 1988 Jan; 21 Suppl A():15-21. PubMed ID: 2965127
    [Abstract] [Full Text] [Related]

  • 5. In vitro activity of teichomycin A 2 in comparison with penicillin and vancomycin against gram-positive cocci.
    Bauernfeind A, Petermüller C.
    Eur J Clin Microbiol; 1982 Oct; 1(5):278-81. PubMed ID: 6223812
    [Abstract] [Full Text] [Related]

  • 6. In vitro activity of teichomycin and vancomycin alone and in combination with rifampin.
    Varaldo PE, Debbia E, Schito GC.
    Antimicrob Agents Chemother; 1983 Mar; 23(3):402-6. PubMed ID: 6221692
    [Abstract] [Full Text] [Related]

  • 7. Comparative in vitro activities of teichomycin and vancomycin alone and in combination with rifampin and aminoglycosides against staphylococci and enterococci.
    Tuazon CU, Miller H.
    Antimicrob Agents Chemother; 1984 Apr; 25(4):411-2. PubMed ID: 6233934
    [Abstract] [Full Text] [Related]

  • 8. Antimicrobial activity of aridicins, novel glycopeptide antibiotics with high and prolonged levels in blood.
    Grappel SF, Giovenella AJ, Phillips L, Pitkin DH, Nisbet LJ.
    Antimicrob Agents Chemother; 1985 Nov; 28(5):660-2. PubMed ID: 3937489
    [Abstract] [Full Text] [Related]

  • 9. Comparison of the in vitro activities of teichomycin A2 and vancomycin against staphylococci and enterococci.
    Cynamon MH, Granato PA.
    Antimicrob Agents Chemother; 1982 Mar; 21(3):504-5. PubMed ID: 6213192
    [Abstract] [Full Text] [Related]

  • 10. In-vitro activity of vancomycin, teicoplanin, daptomycin, ramoplanin, MDL 62873 and other agents against staphylococci, enterococci and Clostridium difficile.
    Bartoloni A, Colao MG, Orsi A, Dei R, Giganti E, Parenti F.
    J Antimicrob Chemother; 1990 Nov; 26(5):627-33. PubMed ID: 1688341
    [Abstract] [Full Text] [Related]

  • 11. Comparative in-vitro activity of LY146032 and eight other antibiotics against gram-positive bacteria isolated from children.
    Kline MW, Mason EO, Kaplan SL, Lamberth LB, Johnson GS.
    J Antimicrob Chemother; 1987 Aug; 20(2):203-7. PubMed ID: 2822647
    [Abstract] [Full Text] [Related]

  • 12. Antimicrobial susceptibility of Gram-positive bacterial isolates from the Asia-Pacific region and an in vitro evaluation of the bactericidal activity of daptomycin, vancomycin, and teicoplanin: a SENTRY Program Report (2003-2004).
    Biedenbach DJ, Bell JM, Sader HS, Fritsche TR, Jones RN, Turnidge JD.
    Int J Antimicrob Agents; 2007 Aug; 30(2):143-9. PubMed ID: 17531446
    [Abstract] [Full Text] [Related]

  • 13. Microbiological properties of teicoplanin.
    Greenwood D.
    J Antimicrob Chemother; 1988 Jan; 21 Suppl A():1-13. PubMed ID: 2965119
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Multidrug-resistant gram-positive pathogens. An update on current microbiological patterns.
    Marchese A, Debbia EA, Bacca D, Balistreri G, Musolino B, Schito GC.
    Drugs; 1997 Jan; 54 Suppl 6():11-20. PubMed ID: 9474477
    [Abstract] [Full Text] [Related]

  • 17. In vitro activity of LY 333328 against anaerobic gram-positive bacteria.
    Sillerström E, Wahlund E, Nord CE.
    J Chemother; 1999 Apr; 11(2):90-2. PubMed ID: 10326737
    [Abstract] [Full Text] [Related]

  • 18. Mode of action and in-vitro activity of vancomycin.
    Watanakunakorn C.
    J Antimicrob Chemother; 1984 Dec; 14 Suppl D():7-18. PubMed ID: 6440886
    [Abstract] [Full Text] [Related]

  • 19. Antimicrobial activity of MDL 62,873, a semisynthetic derivative of teicoplanin, in vitro and in experimental infections.
    Berti M, Candiani G, Borgonovi M, Landini P, Ripamonti F, Scotti R, Cavenaghi L, Denaro M, Goldstein BP.
    Antimicrob Agents Chemother; 1992 Feb; 36(2):446-52. PubMed ID: 1534978
    [Abstract] [Full Text] [Related]

  • 20. [Comparative in vitro activity of daptomycin against gram-positive microorganisms: SENTRY surveillance program, Spain (2002-2006)].
    Loza E, Morosini MI, Pascual A, Tubau F, Alcalá J, Liñares J, Hernández-Bello JR, Baquero F, Perea E, Martín R, Jones RN, Cantón R, SENTRY Surveillance Program, Spain (2002-2006).
    Enferm Infecc Microbiol Clin; 2008 Oct; 26(8):489-94. PubMed ID: 19094861
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.